• Aucun résultat trouvé

Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules

N/A
N/A
Protected

Academic year: 2022

Partager "Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules"

Copied!
5
0
0

Texte intégral

(1)

Inter-nanocarrier and nanocarrier-to-cell transfer assays demon- strate the risk of an immediate unloading of dye from labeled lipid

nanocapsules.

Carl Simonssona,b,‡, Guillaume Bastiata,b,‡,*, Marion Pitorrea,b, Andrey S. Klymchenkoc, Jérôme Béjauda,b, Yves Mélyc, Jean-Pierre Benoita,b

a INSERM, U 1066, Micro et Nanomédecines biomimétiques – MINT, Angers, F-49933 France.

b LUNAM Université, UMR-S1066 Angers, F-49933 France.

c Laboratoire de biophotonique et de Pharmacologie, UMR 7213 CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, 67401 Illkirch, France.

‡ Equal contribution to the work.

* Corresponding author: Guillaume Bastiat. Tel.: +33 244 688531. Fax: +33 244 688546. E-mail guillaume.

bastiat@univ-angers.fr. Complete postal address: MINT – UMR_S1066, Institut de Biologie en Santé – IRIS, 4 rue Larrey CHU, 49933 Angers Cedex 9, France.

Supporting Information.

(2)

Table S1. Size characterization (Z-Ave and PdI) of fluorescent dye-labeled LNCs, for FRET, cell culture, di- alysis and size-exclusion chromatography assays.

Z-Ave (nm) PdI

Methoda Dye [Dye]b mean SD Mean SD nc

F+C+D

LNC60

--- 0 63 3 0.1 0.02 14

C + D NR 1 65 4 0.12 0.05 13

C DiO 1 67 2 0.09 < 0.01 2

C NR / DiO 1 / 1 64 1 0.07 < 0.01 3

F NR 5 58 1 0.15 0.01 3

F F888 5 54 1 0.03 0.01 3

F NR / F888 5 / 5 59 1 0.16 0.01 3

F DiI 3.75 53 1 0.06 0.01 3

F + S

LNC30

--- 0 30 < 1 0.1 < 0.01 2

S NR 1 30 2 0.1 0.01 3

S DiO 1 31 na 0.11 na 1

F NR 5 27 < 1 0.08 0.04 3

F F888 5 28 1 0.05 0.01 3

F NR / F888 5 / 5 27 < 1 0.11 0.02 3

F DiI 3.75 28 1 0.17 0.04 3

F + S

LNC120

--- 0 131 4 0.1 < 0.01 3

S NR 1 150 7 0.13 0.02 3

S DiO 1 118 na 0.09 na 1

F NR 5 126 1 0.1 0.02 3

F F888 5 102 2 0.04 0.01 3

F NR / F888 5 / 5 123 2 0.1 0.02 3

F DiI 3.75 91 1 0.04 0.01 3

a) F: FRET; C: cell culture; D: dialysis; S: size-exclusion chromatography;

b) Dye concentration in Labrafac (mg/mL);

c) Experiment number;

(3)

0 5000 10000 15000

400 500 600 700

Wavelength (nm)

Fluorescence (a.u.)

F888 NR−LNC F888−LNC+LNC F888−LNC+NR−LNC F888 NR−LNC+LNC NR−LNC+LNC

A

0 4000 8000 12000

600 650 700 750 800

Wavelength (nm)

Fluorescence (a.u.)

DiI DiD−LNC DiI−LNC+LNC DiI−LNC+DiD−LNC DiI DiD−LNC+LNC DiD−LNC+LNC

B

0 5000 10000 15000

400 500 600 700

Wavelength (nm)

Fluorescence (a.u.)

F888 NR−LNC F888−LNC+LNC F888−LNC+NR−LNC F888 NR−LNC+LNC NR−LNC+LNC

A

0 5000 10000 15000

600 650 700 750 800

Wavelength (nm)

Fluorescence (a.u.)

DiI DiD−LNC DiI−LNC+LNC DiI−LNC+DiD−LNC DiI DiD−LNC+LNC DiD−LNC+LNC

B

Figure S1. Fluorescence emission spectra for (A) F888/NR-LNC and mixtures of F888-LNC and LNC, F888-LNC and NR-LNC, F888/NR-LNC and LNC, NR-LNC and LNC; with an excitation wavelength of 390 nm; and (B) DiI/DiD-LNC and mixtures of DiI-LNC and LNC, DiI-LNC and DiD-LNC, DiI/

DiD-LNC and LNC, DiD-LNC and LNC; with an excitation wavelength of 549 nm. LNC size was 30 nm and the Labrafac weight ratio was 1:1 for all mixtures. The experiments were repeated in triplicate.

Figure S2. Fluorescence emission spectra for (A) F888/NR-LNC and mixtures of F888-LNC and LNC, F888-LNC and NR-LNC, F888/NR-LNC and LNC, NR-LNC and LNC; with an excitation wavelength of 390 nm; and (B) DiI/DiD-LNC and mixtures of DiI-LNC and LNC, DiI-LNC and DiD-LNC, DiI/DiD-LNC and LNC, DiD-LNC and LNC; with an excitation wavelength of 549 nm. LNC size was 120 nm and the Labrafac weight ratio was 1:1 for all mixtures. The experiments were repeated in triplicate.

(4)

0 25 50 75 100

0.5 1 5 10

Number of THP-1 Cells (x106)

% NR or DiO in LNC after Incubation

DiO-LNC (DiO) NR-LNC (NR) NR/DiO-LNC (DiO) NR/DiO-LNC (NR)

0 100 200

0.5 min 1 min 15 min 30 min Control Incubation Time

Fluorescence Intensity in THP-1 Cells (Geo-Mean, a.u.)

Figure S3. Percentage of NR and DiO in LNCs after incubation for 30 sec. at 25°C of non-labeled THP-1 cells (0.5, 1, 5 and 10 × 106 cells) with DiO-LNC, NR-LNC, or NR/DiO-LNC suspension (1 mg/mL, 60 nm). (n = 3, mean ± standard deviation).

Figure S4. Fluorescence intensity in THP-1 cells after incubation for 30 sec., 1min, 15 min and 30 min at 25°C of non-labeled THP-1 cells (0.5 × 106 cells) with NR-LNC suspension (1 mg/mL, 60 nm), using flow cytometry with NR (FL2 channel) detection. (n = 3, mean ± standard deviation).

(5)

0 100 200

40 20 10 5 1 Control

LNC Concentration (mg/ml)

Fluorescence Intensity in THP-1 Cells (Geo-Mean, a.u.)

0 1 2 3 4 5

DiO NR

Dye Label

% NR or DiO in LNC after Incubation

LNC Concentration:

1 mg/ml 5 mg/ml 10 mg/ml Control

Figure S5. Fluorescence intensity in THP-1 cells after incubation for 30 sec. at 25°C of non-labeled THP-1 cells (0.5 × 106 cells) with NR-LNC suspension (1, 5, 10, 20 and 40 mg/mL, 60 nm), using flow cytometry with NR (FL2 channel) detection. (n = 3, mean ± standard deviation).

Figure S6. Percentage of NR and DiO in LNCs after incubation for 30 sec. at 25°C of NR-THP-1 cells (10

× 106 cells) or DiO-THP-1 cells (2.5 × 106 cells) with non-labeled LNC (1, 5 or 10 mg/mL, 60 nm). Propor- tions were calculated considering NR or DiO-LNC original formulation as 100%. (n = 3, mean ± standard deviation).

Références

Documents relatifs

DESIGN GRAPHIQUE et PHOTO BOUTEILLER COMMUNICATION BESANÇON - IMPRESSION UFC -

In addition to the properties afforded by the gel, nanocarriers can provide additional drug sustained release or different pharmacokinetic and biodistribution profiles than those

Gels support nanocarriers, localize their administration to the target tissue, and sustain drug release, while nanocarriers can provide differentiated

b University of Strasbourg, CNRS UMR7213, Laboratoire de Biophotonique et Pharmacologie, 74 route du Rhin, 67401 Illkirch Cedex, France.. * corresponding

Membrane-free release assays, such as the nanoparticle-to-oil phase extraction assay presented in our previous study or the inter-nanocarrier transfer assays by SEC and FRET used

[r]

Same experiments were performed to study the dye release from oily phase to non-loaded LNCs (reverse method), with the addition of Labrafac TM WL 1349 containing dye (as

The obtained nanocapsules were characterized in terms of average diameter, zeta potential and drug loading in order to check that their properties were maintained after the